(Q48635669)

13 February 2018

title

Three-year follow-up of older schizophrenics: Extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

28 October 2022

0 references

3

E. H. Turner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684118

28 October 2022

author name string

W. F. Hoffman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684118

28 October 2022

L. Ballard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684118

28 October 2022

D. E. Casey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684118

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006322391900057?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

https://api.elsevier.com/content/article/PII:0006322391900057?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

28 October 2022

published in

Biological Psychiatry

1 reference

13 February 2018

volume

30

1 reference

13 February 2018

issue

9

1 reference

13 February 2018

page(s)

913-926

1 reference

13 February 2018

Negative v positive schizophrenia. Definition and validation.

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

A survey of drug-induced extrapyramidal reactions

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia: a 3-year follow-up study

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia in schizophrenic patients: correlation with negative symptoms.

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia: fluctuating patient or fluctuating rater

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Neuroleptic Treatment in Tardive Dyskinesia: Can It Be Developed Into a Clinical Strategy for Long-Term Treatment?1

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Aging and schizophrenic psychosis.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

A diagnostic interview: the schedule for affective disorders and schizophrenia

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Organic psychosis without anemia or spinal cord symptoms in patients with vitamin B12 deficiency

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Five-year follow-up study of tardive dyskinesia

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Seven-year follow-up of tardive dyskinesia in Hungarian outpatients.

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Schizophrenia in the elderly

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Social networks and negative versus positive symptoms of schizophrenia

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Computed tomographic evaluation of patients with tardive dyskinesia

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Neuroleptic-induced parkinsonism in older schizophrenics

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Integrating incidence and prevalence of tardive dyskinesia

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive Dyskinesia in Psychogeriatric Patients: A Five-Year Follow-Up

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

The incidence of negative symptoms in early schizophrenia, mania and other psychoses

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study.

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Computed Tomographic Evidence for Generalized Sulcal and Ventricular Enlargement in Schizophrenia

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

The Nithsdale schizophrenia survey. V. Follow-up of tardive dyskinesia at 3 1/2 years

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Striatal dopamine deficiency in Parkinson's disease: role of aging

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Research Diagnoses for Tardive Dyskinesia

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia: Two-year recovery

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Brain morphology in schizophrenia: a 2- to 5-year CT scan follow-up study

28 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Follow-up study on the reversibility of tardive dyskinesia

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

A simple method for conversion of area ratio measurements of cerebral structures to volume estimates

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

A 10-year follow-up study of tardive dyskinesia--with special reference to the influence of neuroleptic administration on the long-term prognosis

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Follow-up study of 11 patients with potentially reversible tardive dyskinesia

28 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

Tardive dyskinesia: A two-year follow-up study

28 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90005-7

28 October 2022

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018